C56 - Peripheral Neuropathy III: Genetic Testing and Next Generation Sequencing

Event Time: Sunday April 22, 2018 3:30 pm to 5:30 pm
Topic(s): Neuromuscular and Clinical Neurophysiology (EMG)
Director(s): Michael Shy MD
Description: Next generation sequencing testing is making a genetic diagnosis increasingly available and affordable for patients with inherited neuropathies. However, it is increasingly confusing and complex in deciding what genetic testing to perform and how to interpret the results. Expert faculty with extensive experience in ordering and interpreting genetic testing for CMT will review strategies for ordering and interpreting test results, as well as discuss the current state and future of next generation testing for patients with inherited neuropathies and related disorders. This program complements C31: Peripheral Neuropathy I: Anatomical Basis and Acquired Demyelinating Neuropathies and C41: Peripheral Neuropathy II: Diabetic and Inherited Neuropathies, but covers independent topics.
Completion Message: Participants should be able to determine when to consider ordering genetic testing for patients with neuropathy, determine when testing is positive or negative and have an approach of what to do when results are inconclusive, and understand the different forms of next generation sequencing and the strengths and weaknesses of these forms.
CME Credits: 2
Core Competencies: Medical Knowledge, Patient Care

Ready to register for the 2019 AAN Annual Meeting?

Register Now

Related Courses